Valuation: Shamrock Industrial Company Limited

Market Cap 148M 1.54M 1.36M 1.29M 1.17M 2.19M 2.21M 15.43M 5.95M 75.49M 5.79M 5.66M 243M P/E 2025
-53.4x
P/E 2026 -10.7x
Enterprise Value 154M 1.61M 1.42M 1.34M 1.22M 2.28M 2.31M 16.11M 6.21M 78.81M 6.04M 5.91M 254M EV / Sales 2025
-
EV / Sales 2026 609x
Free-Float
48.09%
Yield 2025 *
-
Yield 2026 -
08-14 Shamrock Industrial Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-29 Shamrock Industrial Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 Shamrock Industrial Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
12-22 Shamrock Industrial Company Limited Approves the Proposals for Incorporation of Wholly Owned Subsidiaries CI
12-22 Shamrock Industrial Company Limited Approves the Proposals for Incorporation of Wholly Owned Subsidiaries CI
12-11 Shamrock Industrial Company Limited Announces Incorporation of Wholly Owned Subsidiary HODL Energy Private Limited in India CI
11-14 Shamrock Industrial Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
11-12 Lotus Excel Wealth Creators LLP, HODL Systems LLP, Bagepalli Vijaykumar Harish and Rattan Kapoor completed the acquisition of 0.38% stake in Shamrock Industrial Company Limited for INR 0.34 million. CI
25-10-28 Shamrock Industrial appoints Rahul Manoj Rajani as chief financial officer RE
25-10-28 Shamrock Industrial Company Limited Approves Appointment of Rahul Manoj Rajani as Chief Financial Officer, Effective October 28, 2025 CI
25-10-28 Shamrock Industrial Company Limited Announces Board Appointments, Effective October 28, 2025 CI
25-10-16 Shamrock Industrial Company Limited Announces Resignation of Jitesh Rameshchandra Khokhani as Chief Financial Officer, with Effect from Closure of Business Hours of October 16, 2025 CI
25-10-16 Shamrock Industrial Company Limited Announces Board Resignations, with Effect from October 16, 2025 CI
Current month+4.97%
1 month+4.97%
3 months+15.66%
6 months+27.46%
Current year+40.46%
1 week 27.25
Extreme 27.25
27.25
1 month 25.96
Extreme 25.96
27.25
Current year 19.4
Extreme 19.4
27.25
1 year 17.6
Extreme 17.6
27.25
3 years 3.75
Extreme 3.75
27.25
5 years 3.16
Extreme 3.16
27.25
10 years 3.16
Extreme 3.16
27.25
Manager TitleAgeSince
Chief Executive Officer - 2025-10-15
Director of Finance/CFO - 2025-10-27
Chief Operating Officer - 2025-10-27
Director TitleAgeSince
Director/Board Member - 2021-06-21
Director/Board Member - 2022-04-20
Director/Board Member - 2025-10-15
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+54.83%+516.52% 1.54M
-0.01%+1.24%+63.06%+120.55% 1,056B
-1.61%-0.60%+47.32%+71.79% 655B
-1.12%-0.72%+17.98%+76.63% 471B
-1.72%-4.06%+36.39%+39.47% 342B
-0.40%+3.83%+22.08%+28.82% 277B
-0.51%-1.05%+12.98%+12.92% 257B
+1.32%+3.27%+54.63%+57.63% 226B
-0.61%-0.91%+34.33%+101.87% 189B
-0.24%-2.76%-28.41%-60.92% 170B
Average -0.17%+0.87%+31.52%+96.53% 364.29B
Weighted average by Cap. -0.05%+1.04%+38.98%+70.59%

Financials

2025 2026
Net sales - 201K 2.09K 1.85K 1.75K 1.59K 2.97K 3K 20.98K 8.09K 103K 7.87K 7.69K 330K
Net income -1.26M -13.13K -11.59K -10.96K -9.94K -18.64K -18.83K -132K -50.69K -643K -49.31K -48.23K -2.07M -10.87M -113K -99.93K -94.55K -85.75K -161K -162K -1.13M -437K -5.55M -425K -416K -17.86M
Net Debt -137K -1.43K -1.26K -1.19K -1.08K -2.03K -2.05K -14.3K -5.51K -69.96K -5.36K -5.24K -225K 6.49M 67.68K 59.72K 56.51K 51.25K 96.08K 97.03K 678K 261K 3.32M 254K 249K 10.67M
Logo Shamrock Industrial Company Limited
Shamrock Industrial Company Limited is an India-based pharmaceuticals company. The Company offers a diverse range of manufacturing of pharmaceuticals and drugs products and allied business activities. It offers its products for various therapeutic uses, including anti-coagulants (anti-platelet), radio-protective agents, platelet regulator, anti-depressants, anti-neo plastics and immunosuppressants, antihistamines, sympathomimetics, anti-hypertensives, diuretic, anti-diabetic, calcium regulating agents, local anesthetics and anti-bacterial. Its active pharmaceutical ingredient (API) product list (manufactured) includes acenocomarol, amifostine, ciclopirox, cilazapril, losartan potassium, metaxalone, metoprolol succinate and pregabalin. The Company's API product list (contract manufactured) includes abacavir, acarbose, oxaliplatin, oxaprozin, finasteride, frusemide and colchicine.
Employees
1
Date Price Change Volume
26-09-28 ₹27.25 0.00% 1,520
  1. Stock Market
  2. Stocks
  3. 531240 Stock